Application

14857344 · MONOSPECIFIC AND BISPECIFIC ANTI-IGF-1R AND ANTI-ERBB3 ANTIBODIES

Filed 2015-09-17 · Granted · Patent 9527914 (2016-12-27) The official file ↗The patent and its PDF ↗ · Art unit 1643 · Examiner Jessica Hope Roark Typical · CPC C07K 16/28 · Merrimack Pharmaceuticals, Inc. · NELSON MULLINS RILEY & SCARBOROUGH LLP/MERRIMACK

Office actions

first was Non-final rejection

RCEs

no appeal

To first action

5.1 mo

to disposition 15.3 mo

Statutes raised

112 DP

2 actions read

Unlock the prosecution timelineIncluded in Pro, from $29 a month. Cancel any time.